March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Role of iC3b-CR3 interaction in Experimental Autoimmune Anterior Uveitis
Author Affiliations & Notes
  • Bharati Matta
    Ophthalmology, Jones Eye Institute-UAMS, Little Rock, Arkansas
  • Purushottam Jha
    Ophthalmology, Jones Eye Institute-UAMS, Little Rock, Arkansas
  • Puran S. Bora
    Ophthalmology, Jones Eye Institute-UAMS, Little Rock, Arkansas
  • Nalini S. Bora
    Ophthalmology, Jones Eye Institute-UAMS, Little Rock, Arkansas
  • Footnotes
    Commercial Relationships  Bharati Matta, None; Purushottam Jha, None; Puran S. Bora, None; Nalini S. Bora, None
  • Footnotes
    Support  NIH grant EY018812 and the grant from Pat and Willard Walker Eye Research Center, Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR.
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6237. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Bharati Matta, Purushottam Jha, Puran S. Bora, Nalini S. Bora; Role of iC3b-CR3 interaction in Experimental Autoimmune Anterior Uveitis. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6237.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To explore the role of interaction between complement activation product - iC3b and its receptor CR3 in experimental autoimmune anterior uveitis (EAAU).

Methods: : Male Lewis rats (5-6 weeks old) were immunized with bovine melanin associated antigen (MAA) emulsified (1:1) in complete Freund’s adjuvant (CFA) in the hind footpad. Animals were sacrificed on different days post-immunization and lymphocytes were purified from the popliteal lymph nodes (LNs) using histopaque gradient. Lymphocytes were stained with anti-CD4 APC and anti-iC3b followed by staining with FITC labeled secondary antibody (Ab). In a separate set of experiment, cells were stained with anti-CD11b/c PE, anti-CD3-APC, anti-CD45RA-FITC and anti-iC3b followed by staining with PerCP labeled secondary Ab. CFSE labeled lymphocytes purified from the popliteal LNs on day 5 post-immunization were plated in serum free CellGroR Medium containing rat iC3b in the presence of different concentration of anti-CD11b and anti-iC3b Abs separately for 5 days in the presence of bovine MAA (20 µg/ml). On day 6 non-adherent cells were collected and stained with anti-CD4-APC. The proliferation data was collected using FACS Calibur and was analyzed using Win MDI.

Results: : During the induction of EAAU, iC3b is deposited on antigen presenting cells (APCs) and CD4+ T cells present in the popliteal LNs. Out of total CD4+ T cells, the percentage of CD4+ T cells that are positive for iC3b started to increase as early as day 2, peaked on day 7 post-immunization and started to decrease after that. Out of total CD11b/c+ CD3- CD45RA- cells, the percentage of cells that are iC3b positive sharply increased at day 2 and peaked on day 7 post-immunization. Treatment with anti-CD11b and anti-iC3b Abs separately inhibited the proliferation of CD4+ T cells in response to MAA in a dose dependent manner.

Conclusions: : Our results demonstrate that during the induction phase of EAAU, iC3b is deposited on CD4+ T cells and CD11b/c+ CD3- CD45RA- APCs that are present in the popliteal LNs of MAA sensitized Lewis rats. Our data further suggest that the interaction between iC3b and its receptor CR3 modulates CD4+ T cells responses in EAAU.

Keywords: autoimmune disease • inflammation • uveitis-clinical/animal model 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×